Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-kappa B Inducing Kinase.
Blaquiere, N., Castanedo, G.M., Burch, J.D., Berezhkovskiy, L.M., Brightbill, H., Brown, S., Chan, C., Chiang, P.C., Crawford, J.J., Dong, T., Fan, P., Feng, J., Ghilardi, N., Godemann, R., Gogol, E., Grabbe, A., Hole, A.J., Hu, B., Hymowitz, S.G., Alaoui Ismaili, M.H., Le, H., Lee, P., Lee, W., Lin, X., Liu, N., McEwan, P.A., McKenzie, B., Silvestre, H.L., Suto, E., Sujatha-Bhaskar, S., Wu, G., Wu, L.C., Zhang, Y., Zhong, Z., Staben, S.T.(2018) J Med Chem 61: 6801-6813
- PubMed: 29940120 
- DOI: 10.1021/acs.jmedchem.8b00678
- Primary Citation of Related Structures:  
6G4Y, 6G4Z - PubMed Abstract: 
NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism ...